Neu2000, promising neuroprotectant to treat ischemic stroke

Neu2000 remains the primary focus of the drug’s development. Neu2000’s strong anti-oxidation activity, its potent NMDA antagonist activity, and its anti-zinc protective activity make it a promising neuroprotectant to treat ischemic stroke, according to Neurotech Pharmaceuticals, a local biopharmaceutical company.

The company said the results of Phase I clinical trial for Neu2000 was carried ...